2021 (v1)
Publication
No description
Uploaded on: February 13, 2024
-
-
2017 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2016 (v1)Publication
The 5th European Conference on Infections in Leukaemia (ECIL-5) meeting aimed to establish evidence-based recommendations for the prophylaxis of Pneumocystis jirovecii pneumonia (PCP) in non-HIV-infected patients with an underlying haematological condition, including allogeneic HSCT recipients. Recommendations were based on the grading system...
Uploaded on: May 13, 2023 -
2016 (v1)Publication
Pneumocystis jirovecii can cause life-threatening pneumonia following treatment for haematological malignancies or after HSCT. The mortality rate of P. jirovecii pneumonia (PCP) in these patients is 30%-60%, especially after HSCT. The clinical presentation of PCP in haematology differs from that associated with HIV infection, with the disease...
Uploaded on: May 13, 2023 -
2016 (v1)Publication
The Fifth European Conference on Infections in Leukaemia (ECIL-5) convened a meeting to establish evidencebased recommendations for using tests to diagnose Pneumocystis jirovecii pneumonia (PCP) in adult patients with haematological malignancies. Immunofluorescence assays are recommended as the most sensitive microscopic method (recommendation...
Uploaded on: May 13, 2023